Delivery Order SPE2DB20D3101-SPE2DB25FRMP1
Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $44K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,946.55 to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye DR 100s. This is a firm fixed price, non-set-aside contract awarded on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 16,000 units of Pertzye capsules (pancrelipase 16,000 USP units) valued at $8,939.24 under a firm fixed price contract. This non-set-aside award, issued on August 28, 2025, with completion targeted for August 29, 2025, represents a routine pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $21,717.63 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Pertzye DR 200S on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside, firm fixed price delivery order is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $4,464.24 firm fixed price delivery order to AmerisourceBergen Drug Corp for 24,000 unit capsules of Pertzye on June 9, 2025, with an ultimate completion date of June 10, 2025. This non-set-aside contract represents a routine pharmaceutical supply delivery executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Pertzye (pancrelipase) capsules—16,000 units in 100-count bottles. This competitive, non-set-aside contract has a ceiling value of $5,750.73 and a firm fixed price structure, with an ultimate completion date of October 29, 2025. The contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a $4,046.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye DR 100s, a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency. The award, issued on July 16, 2025, with an ultimate completion date of July 17, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing contract vehicle. Performance will be executed at the company's corporate office location in...
- This delivery order, awarded on July 24, 2025, represents a $4,046.28 firm fixed-price purchase of Pertzye (pancrelipase) 16,000 unit capsules in quantities of 100 capsules, issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain. The contract is a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 25, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Pertzye is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $10,076.37 for 24,000 unit capsules of Pertzye (pancrelipase) with an 80-strength formulation. The contract, awarded on November 6, 2025, with a completion date of November 7, 2025, operates under a firm fixed-price structure and is not designated as a set-aside contract. This delivery order is a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $9,735.52 to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye DR 100s on July 24, 2025, with completion expected by July 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement for federal medical needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 unit capsules of the medication Pertzye DR, a pancreatic enzyme replacement therapy, at a firm fixed price of $10,241.07. The contract has an ultimate completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...